Search
Search
Close this search box.

New York’s CCB Issues 114 New Cannabis Licenses & Waives Cultivator Licensing Fees For 2 Years

New York’s Cannabis Control Board (CCB) has approved 114 new cannabis licences as part of the second round of licensing.

On Friday (March 22), the board of the CCB voted to approve the new licences after receiving around 7000 applications, including 4300 for dispensaries, during the latest licensing window, which ended in December 2023.

Of the newly issued licences 45 were dispensaries, 31 were for microbusinesses, and 38 were non-conditional adult-use permits. The meeting also saw the board vote to renew 17 permits for cannabis testing labs.

Last month, a further 25 retail and 26 microbusiness licences were approved.

The meeting came amid growing pressure on the CCB and the Office for Cannabis Management (OCM), with reports emerging last week that Governor Kathy Hochul had launched a ‘top down’ internal review of the latter.

This review was called in response to major frustrations about the establishment of New York’s adult-use cannabis market, which has been mired by a plethora of lawsuits and has placed a number of legitimate businesses in financial jeopardy due to its slow and often poorly handled rollout.

In an effort to offer some respite to New York’s cannabis cultivators, the CCB also voted to waive cultivator licensing fees, which cost anywhere from $4,500 to $40,000, for two years.

While 146 cultivation licenses were approved in 2022, with more following in the subsequent months, the snail’s pace of licensing meant that they had just 20 dispensaries to sell to for the majority of 2023.

Following the latest round of licensing, 87 licensed retailers are now operating in the state. However, it’s now estimated that there are over 2000 illicit stores in operation.

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?